DSM Nutritional Products reports women’s health breakthrough
Due to an ageing population, bone loss and the resulting increased risk of bone fracture is a growing problem globally. Approximately a third of postmenopausal women in USA and Europe are affected.
The clinical trial, conducted in collaboration with Creighton University, Omaha, USA, took the form of a pilot, randomized, placebo-controlled, double-blind study in 58 healthy, early postmenopausal women. The geniVida™ Bone Blend is a patent protected combination of geniVida™ brand pure genistein, omega-3 fatty acids EPA and DHA, and the vitamins D3 and K1.
William Black, Vice-President of New Nutritional Ingredients at DSM, says: “The new study provides evidence of the significant health benefits offered by a multi-nutrient solution to a multifactorial health issue such as bone mineral density. This new evidence complements previous data showing significant menopause symptom (hot flush) relief for post-menopausal women supplementing with geniVida™ genistein. geniVida™ therefore potentially offers solutions for unmet short-term and long-term health needs for mature women”.